Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|February 3, 2018
Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-upPeter Deibert, Adhara Lazaro, Zoran Stankovic, et al.
The Annals of Thoracic Surgery|July 5, 2003
Cavoatrial bypass for occlusion of the inferior caval vein in a patient with Budd-Chiari syndromeMarkus P Wilhelm, Gerhard Spillner, Martin Rössle, et al.
Macromolecular Bioscience|December 14, 2011
Photocrosslinked co-networks from glycidylmethacrylated gelatin and poly(ethylene glycol) methacrylatesBenjamin F Pierce, Giuseppe Tronci, Martin Rössle, et al.
Digestion|April 19, 2002
Effect of the somatostatin analogue lanreotide on meal-stimulated portal blood flow in patients with liver cirrhosisPeter Schiedermaier, Phillip Harrison, Michael Arthur, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 21, 2017
Rapid change of liver stiffness after variceal ligation and TIPS implantationFelix Piecha, Daniel Paech, Janina Sollors, et al.
Cardiovascular and Interventional Radiology|February 22, 2019
Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate EmbolizationMichael Schultheiß, Max Giesler, Lars Maruschke, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
JMIR Research Protocols|April 7, 2026
Enhancing Continuous Medication Safety Through e-Prescription and Clinical Decision Support Systems in Outpatient Practices and Pharmacies: Protocol for a Multiperspective Study (eRIKA Study)Juliana Schmidt, David Lampe, Adriana Poppe, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-RegistryHartwig Klinker, Uwe Naumann, Martin Rössle, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 8, 2002
Human insulin release processes measured by intraportal samplingNiels Pørksen, Thorbjørn Grøfte, Jacob Greisen, et al.
Pageof 6